Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Zymeworks Inc (NQ: ZYME ) 10.38 +0.12 (+1.17%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 374,141 Open 10.26 Bid (Size) 10.05 (1) Ask (Size) 10.63 (1) Prev. Close 10.26 Today's Range 10.11 - 10.54 52wk Range 6.015 - 13.14 Shares Outstanding 57,771,204 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW191, a Novel Folate Receptor-⍺ Targeted Topoisomerase I Inhibitor Antibody-Drug Conjugate July 22, 2024 From Zymeworks Inc. Via GlobeNewswire Zymeworks To Report Second Quarter 2024 Financial Results and Host Conference Call on August 1, 2024 July 11, 2024 From Zymeworks Inc. Via GlobeNewswire Performance YTD N/A N/A 1 Month +23.57% +23.57% 3 Month +19.17% +19.17% 6 Month +3.28% +3.28% 1 Year +40.46% +40.46% More News Read More Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW171, a novel 2+1 T-cell Targeting Bispecific Antibody for Mesothelin-expressing Cancers June 17, 2024 From Zymeworks Inc. Via GlobeNewswire Navigating 6 Analyst Ratings For Zymeworks June 06, 2024 Via Benzinga Week In Review: Osaka Enters $445 Million Deal For Two Hearing Loss Candidates From France's Cilcare June 15, 2024 Via Talk Markets Zymeworks Announces China NMPA Acceptance of Biologics License Application for Zanidatamab for Second-Line Treatment of Biliary Tract Cancer June 10, 2024 From Zymeworks Inc. Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
